Tacrolimus Ointment
Product Images NDC 16729-421

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Tacrolimus (NDC 16729-421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Tacrolimus Figure 1)

A line graph showing percentage of body surface area affected over 12 weeks for Tacrolimus ointment. The graph compares Vehicle, 0.03%, and 0.1% strengths. The y-axis represents % body surface area affected with mean ± 95% CI, and the x-axis shows time in weeks. Both 0.03% and 0.1% strengths reduce affected area more than Vehicle over time.*

FDA Label Image

Figure 2 (Tacrolimus Figure 2)

A line graph showing the percentage of body surface area affected over 12 weeks. The graph compares two groups: one treated with Vehicle and the other with 0.03% concentration, with data points and error bars indicating variability around the mean at multiple time intervals.*

FDA Label Image

Figure 3 (Tacrolimus Figure 3)

A line graph showing mean erythema scores over 12 weeks with three treatment groups: Vehicle, 0.03%, and 0.1%. The y-axis represents mean erythema score with 95% confidence intervals, and the x-axis represents time in weeks. Scores decrease over time for 0.03% and 0.1%, while Vehicle remains relatively constant.*

FDA Label Image

Figure 4 (Tacrolimus Figure 4)

A line graph showing mean erythema scores (mean ± 95% CI) over 12 weeks comparing vehicle and 0.03% Tacrolimus topical ointment. The x-axis represents time in weeks (0 to 12), and the y-axis shows the mean erythema score (0 to 2). The 0.03% Tacrolimus group shows a decreasing erythema score over time, while the vehicle group remains relatively stable.*

FDA Label Image

Tacrolimus Ointment-0.03%-30g Box (Tacrolimus Ointment 003 30g Box)

Packaging label for Tacrolimus Ointment 0.03% topical ointment by Accord Healthcare Inc. The label shows a 30g tube size and includes directions for use and storage information. The label notes the product is Rx only and intended for dermatologic use, not ophthalmic use. The Accord logo and NDC number 16729-421-10 are visible.*

FDA Label Image

Tacrolimus Ointment-0.03%-30g Foil (Tacrolimus Ointment 003 30g Foil)

Label for Tacrolimus Ointment 0.03% topical ointment in a 30g size. The label includes usage instructions, storage conditions, and manufacturer information for Accord Healthcare Inc. The product is for dermatologic use and prescription only.*

FDA Label Image

Tacrolimus Ointment-0.03%-60g Box (Tacrolimus Ointment 003 60g Box)

Packaging label for Tacrolimus Ointment 0.03%, topical ointment, 60g vial. The label shows the product name, strength, dosage form, and net weight. It includes dispensing instructions, storage conditions, and warnings. The labeler is Accord Healthcare Inc. The design features green and black text on a white background with Accord's logo.*

FDA Label Image

Tacrolimus Ointment-0.03%-60g Foil (Tacrolimus Ointment 003 60g Foil)

Label for Tacrolimus Ointment 0.03%, a topical prescription drug by Accord Healthcare Inc. The label states the net weight as 60g and includes warnings such as not for ophthalmic use and to keep out of reach of children. The ointment contains 0.03% tacrolimus USP in a base of white petrolatum, mineral oil, propylene carbonate, white wax, and paraffin. Usage instructions note applying twice daily with storage at controlled room temperature. Manufactured by Intas Pharmaceuticals Limited, India.*

FDA Label Image

Tacrolimus Ointment-0.1%-100g Box (Tacrolimus Ointment 01 100g Box)

Packaging label for Tacrolimus Ointment 0.1% topical ointment. The carton is for a 100g tube and includes warnings to dispense with an enclosed medication guide, for dermatologic use only. The labeler is Accord Healthcare Inc. The NDC is 16729-422-01.*

FDA Label Image

Tacrolimus Ointment-0.1%-100g Foil (Tacrolimus Ointment 01 100g Foil)

Tacrolimus Ointment 0.1% topical ointment label by Accord Healthcare Inc. The label indicates a 100 g package size and includes usage warnings such as 'For dermatologic use only' and 'Not for ophthalmic use.' It details the concentration of tacrolimus at 0.1% w/w in a base containing white petrolatum, mineral oil, propylene carbonate, white wax, and paraffin. Storage instructions specify controlled room temperature conditions. Manufactured by Intas Pharmaceuticals Limited in India for Accord Healthcare Inc., Durham, NC.*

FDA Label Image

Tacrolimus Ointment-0.1%-30g Box (Tacrolimus Ointment 01 30g Box)

Tacrolimus Ointment 0.1% topical ointment packaging label from Accord Healthcare Inc. The 30g carton displays the product name, strength, and instructions to dispense with an enclosed medication guide for dermatologic use only. Storage and usage warnings are included, along with the labeler logo and a barcode.*

FDA Label Image

Tacrolimus Ointment-0.1%-30g Foil (Tacrolimus Ointment 01 30g Foil)

Label for Tacrolimus Ointment 0.1%, a 30g topical ointment by Accord Healthcare Inc. The label includes usage warnings, dosage instructions to apply twice daily, and storage conditions. It notes the active ingredient concentration as 0.1% w/w and indicates it is for dermatologic use only, not for ophthalmic use. Manufacturer details for Intas Pharmaceuticals Limited and Accord Healthcare Inc. are also present.*

FDA Label Image

Tacrolimus Ointment-0.1%-60g Box (Tacrolimus Ointment 01 60g Box)

Tacrolimus Ointment 0.1% topical ointment packaging label from Accord Healthcare Inc. The label states the product strength as 0.1% w/w and the package contains 60 grams. It includes usage warnings noting the ointment is for dermatologic use only and not for ophthalmic use, along with storage instructions and manufacturer details. The design features a white background with blue and black text.*

FDA Label Image

Tacrolimus Ointment-0.1%-60g Foil (Tacrolimus Ointment 01 60g Foil)

Tacrolimus Ointment 0.1% topical ointment label showing a 60g tube. The label includes usage warnings, storage instructions, and manufacturer information for Accord Healthcare Inc. The active ingredient concentration is 0.1% w/w, with detailed excipient components listed. The label specifies dermatologic use only and notes dispensing with enclosed medication guide.*

FDA Label Image

Tacrolimus Ointment-100g Box (Tacrolimus Ointment 100g 003 Box)

Packaging label for Tacrolimus Ointment 0.03% topical ointment by Accord Healthcare Inc. The label shows a 100g carton with warnings to dispense with enclosed medication guide and for dermatologic use only. The label includes storage instructions, barcode, and manufacturer information.*

FDA Label Image

Tacrolimus Ointment-0.03%-100g Foil (Tacrolimus Ointment 100g 003 Foil)

Tacrolimus Ointment 0.03% topical ointment label shows a 100g container from Accord Healthcare Inc. The label includes usage instructions emphasizing dermatalogic use only and warnings. Manufacturing information lists Intas Pharmaceuticals Limited in India and Accord Healthcare Inc. in Durham, NC. The ointment contains 0.03% w/w tacrolimus in a base of white petrolatum, mineral oil, propylene carbonate, white wax, and paraffin.*

FDA Label Image

Structure (Tacrolimus Structural Formula)

Chemical structure diagram of Tacrolimus, showing its molecular framework including atoms, bonds, and a hydrate component indicated by \u00b7H2O.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.